Aptadir Therapeutics raised €40M in a Seed round in Sep 2026. The company is based in Milano, Italy. Investors in the round: 4BIO Capital, CDP Venture Capital, CE-Ventures and 2 others. Data as of 29 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
